The confirmatory trial in comparative-effectiveness research

New England Journal of Medicine

Volumn 361, Issue 15, 2009, Pages 1498-1499

  Garber, Alan M ^a,b   Hlatky, Mark A ^b  

^a VA PALO ALTO HEALTH CARE SYSTEM   (United States)

^b STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL RESEARCH; DEFIBRILLATOR; EDITORIAL; HEART INFARCTION; HUMAN; MEDICAL LITERATURE; OUTCOMES RESEARCH; PRIORITY JOURNAL; SUDDEN DEATH; FINANCIAL MANAGEMENT; HEALTH SERVICES RESEARCH; LEGAL ASPECT; NOTE; RANDOMIZED CONTROLLED TRIAL;

DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; FINANCING, GOVERNMENT; HEALTH SERVICES RESEARCH; HUMANS; MYOCARDIAL INFARCTION; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 70349974834     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMe0907125     Document Type: Editorial

References (9)

1. Institute of Medicine, Committee on Comparative Effectiveness Research Prioritization. Initial national priorities for comparative effectiveness research. Washington, DC: National Academies Press, 2009.
2. Garber AM, Meltzer DO. Setting priorities for comparative effectiveness research. In: Implementing comparative effectiveness research: priorities, methods, and impact. Washington, DC: Brookings Institution, 2009:15-33. (Accessed September 17, 2009, at http://www.brookings.edu/~/media/Files/events/ 2009/0609-health-care-cer/0609-health-care-cer.pdf.)
3. Steinbeck G, Andresen D, Seidl K, et al. Defibrillator implantation early after myocardial infarction. N Engl J Med 2009;361:1427-1436
4. Solomon SD, Zelenkofske S, McMurray JJ, et al. Sudden death in patients with myocardial infarction and left ventricular dysfunction, heart failure, or both. N Engl J Med 2005;352:2581-2588 [Erratum, N Engl J Med 2005;353:744.]
5. Ezekowitz JA, Rowe BH, Dryden DM, et al. Systematic review: implantable cardioverter defibrillators for adults with left ventricular systolic dysfunction. Ann Intern Med 2007;147:251-262
6. Hohnloser SH, Kuck KH, Dorian P, et al. Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction. N Engl J Med 2004;351:2481-2488 (Pubitemid 39603155)
7. Wilber DJ, Zareba W, Hall WJ, et al. Time dependence of mortality risk and defibrillator benefit after myocardial infarction. Circulation 2004;109:1082-1084 (Pubitemid 38332609)
8. Poole JE, Johnson GW, Hellkamp AS, et al. Prognostic importance of defibrillator shocks in patients with heart failure. N Engl J Med 2008;359:1009-1017
9. Epstein AE, DiMarco JP, Ellenbogen KA, et al. ACC/AHA/ HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices) developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. J Am Coll Cardiol 2008;51(21):e1-e62. [Errata, J Am Coll Cardiol 2009;53:147, 1473.]